| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/29/2002 | EP1207890A2 Antiviral prodrugs |
| 05/29/2002 | EP1207886A2 Sphingomyelinase inhibitor |
| 05/29/2002 | EP1207884A2 Use of cgrp antagonists and cgrp release inhibitors for controlling menopausal hot flashes |
| 05/29/2002 | EP1207882A1 Acyclic and cyclic amine derivatives |
| 05/29/2002 | EP1207878A2 Treatment of migraine by the administration of alpha-lipoic acid or derivatives thereof |
| 05/29/2002 | EP1207876A1 Use of proteinase inhibitor in order to inhibit the cleavage of growth factor precursor |
| 05/29/2002 | EP1207873A1 Methods of inhibiting osteoclast activity |
| 05/29/2002 | EP1207863A2 New uses for potassium channel openers, such as the treatment of epilepsy |
| 05/29/2002 | EP1207856A2 Coformulation methods and their products |
| 05/29/2002 | EP1207840A1 Pharmaceutical compositions and methods for reducing the appearance of cellulite |
| 05/29/2002 | EP1207811A1 Nitric oxide releasing medical devices |
| 05/29/2002 | EP1207755A1 Methods of and compositions for inhibiting the proliferation of mammalian cells |
| 05/29/2002 | EP1061812A4 Food products having enhanced cocoa polyphenol content and processes for producing same |
| 05/29/2002 | EP0991637B1 Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives as farnesyl protein transferase inhibitors |
| 05/29/2002 | EP0889971B1 Phosphatase modulator |
| 05/29/2002 | EP0799023B1 Use of flavonoids as immunomodulating or immuno-protective agents in cosmetic and dermatological preparations |
| 05/29/2002 | EP0678021B1 Methods for the improvement of cognition with partial agonists of the glycine nmda receptor complex |
| 05/29/2002 | DE10057976A1 Verfahren zur Herstellung von Pektinhydrolyseprodukten A process for producing pectin hydrolysis products |
| 05/29/2002 | DE10055742A1 Neue Polyester, Verfahren zu ihrer Herstellung und aus den Polyestern hergestellte Depot-Arzneiformen New polyester, process for their preparation and depot dosage forms prepared from the polyesters |
| 05/29/2002 | CN1351614A Human antibodies that bind human IL-12 and methods for producing |
| 05/29/2002 | CN1351608A B-methyl-erythromycin derivatives |
| 05/29/2002 | CN1351604A Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease |
| 05/29/2002 | CN1351601A Heterocyclic compounds binding chemotactic factor receptor |
| 05/29/2002 | CN1351599A Indole-type derivatives as inhibitors of P38 kinase |
| 05/29/2002 | CN1351595A Substituted polycyclic aryl and heteroacryl pyrazinones useful for selective inhibition of the coagulation cascade |
| 05/29/2002 | CN1351594A Substituted polycyclic aryl and heteroaryl uracils as anticoagulative agents |
| 05/29/2002 | CN1351593A Substituted polycyclic aryl and heteroaryl pyrymidinones useful as anticoagulants agents |
| 05/29/2002 | CN1351592A Acyl derivatives which treat VL4-4 related disorders |
| 05/29/2002 | CN1351591A 抗炎吲哚衍生物 Indomethacin derivative |
| 05/29/2002 | CN1351589A Vitamin D analogues and their pharmaceutical use |
| 05/29/2002 | CN1351587A Use of 2,4-diamino-3-hydroxycarboxylic acid derivatives as proteasome inhibitors |
| 05/29/2002 | CN1351498A Pyrrolotriazines inhibitors of kinases |
| 05/29/2002 | CN1351497A Aminopyrimidines as sorbitol dehydrogenase inhibitors |
| 05/29/2002 | CN1351496A Medicaments containing inhibitors of cell-volume regulated human kinase h-sgk |
| 05/29/2002 | CN1351491A Salts of cis-[4-cyano-4-(3-cyclopentyloxy-4-methoxyphenyl)cyclohexan-1-carboxylate] |
| 05/29/2002 | CN1351490A Use of 15-deoxyspergualin for the treatment of hyperreactive inflammatory diseases and autoimmune diseases |
| 05/29/2002 | CN1351174A Inhibiting material for inverting enzyme for angiotensin I |
| 05/29/2002 | CN1350872A Face-beautifying and health-care method by importing to acupoints on human body |
| 05/29/2002 | CN1085668C 6-[triazoly[3-(trifluoromethyl)phenyl)methyl]-2-quinolinones and quinolinethiones |
| 05/29/2002 | CN1085666C 6-aryl pyrido (2,3-d) pyrimidines and naphthyridines for inhibiting protein tyro sine kinase medicated cellular proliferation |
| 05/29/2002 | CN1085537C Hog cholera treating medicine |
| 05/29/2002 | CN1085528C Use of benzydamine in treatment of pathological conditions caused by TNF |
| 05/29/2002 | CN1085527C Preparation method of synergistic antimalarial compound benzfluorenol |
| 05/28/2002 | US6395919 Calcilytic compounds |
| 05/28/2002 | US6395909 Drugs for anticonvulsants |
| 05/28/2002 | US6395905 Tetrahydroindazole derivatives as ligands for GABA-A α 5 receptors |
| 05/28/2002 | US6395897 Drugs for enzyme inhibitors anticoagulants and treatment of autoimmune disease |
| 05/28/2002 | US6395882 Selectin ligands |
| 05/28/2002 | US6395780 Prevent glucose degradation |
| 05/28/2002 | US6395768 Preventing cytotoxic effect of amyloid protein; oxidation, stress resistance |
| 05/28/2002 | US6395767 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method |
| 05/28/2002 | US6395763 Antitumor, anticancer agents; immunosuppressant |
| 05/28/2002 | US6395754 Antiinflammatory agents, cardiovascular disorders, antipyretics |
| 05/28/2002 | US6395740 Calcitonin mimetics |
| 05/28/2002 | US6395737 Malonic acid derivatives, processes for their preparation, for their use and pharmaceutical compositions containing them |
| 05/28/2002 | US6395736 Compositions and methods for the treatment of anorectal disorders |
| 05/28/2002 | US6395734 Anticancer agents |
| 05/28/2002 | US6395731 Anticoagulants |
| 05/28/2002 | US6395730 Potassium channel inhibitors |
| 05/28/2002 | US6395729 Use of pyridazino[4,5-b]indole-1-acetamide derivatives for preparing medicines for treating diseases related to the dysfunction of peripheral benzodiazepin receptors |
| 05/28/2002 | US6395725 Prevention or reverse drug resistance |
| 05/28/2002 | US6395724 Multibinding inhibitors of cyclooxygenase-2 |
| 05/28/2002 | US6395722 Fatty acid derivatives of bile acids and bile acid derivatives |
| 05/28/2002 | US6395720 Anticancer agents |
| 05/28/2002 | US6395719 Methods for increasing levels of acetylcholine |
| 05/28/2002 | US6395717 Sialic acid polymer |
| 05/28/2002 | US6395707 Methods of treatment utilizing variants of vascular endothelial cell growth factor |
| 05/28/2002 | US6395514 Polynucleotides encoding chemokineα-5 |
| 05/28/2002 | US6395510 Vertebrate apoptosis gene: compositions and methods |
| 05/28/2002 | US6395502 Method and means for modulating PGE synthase activity |
| 05/28/2002 | US6395497 Suppression of leukocyte transferring in humans; administer immunoglobulins to humans, detect bound receptor, evaluate immune response |
| 05/28/2002 | US6395476 Evaluating long term outcome of viral disease infection; obtain sample, obtain viral nucleotide sequence from sample, screen sequences for presence of mutation in preferential codon, presence of mutation indicate more sever viral disease |
| 05/28/2002 | US6395474 Peptide nucleic acids |
| 05/28/2002 | US6395309 Use of an extract of Alchemilla vulgaris to inhibit angiogenesis |
| 05/28/2002 | US6395281 Cosmetic skin conditioning compositions containing red yeast rice extract |
| 05/28/2002 | US6395276 Killing malignant b cells by contacting with protein having ribonuclease activity linked to antibody against b cell surface marker; anticancer agents |
| 05/28/2002 | US6395270 Activated protein C formulations |
| 05/28/2002 | US6395260 Topical cosmetic compositions comprising benzaldoximes |
| 05/28/2002 | US6394812 Vivo induction for enhanced function of isolated hepatocytes |
| 05/28/2002 | CA2325014C 8-chloro-6,11-dihydro-11-(4-piperidylidene)-5h-benzo[5,6]cyclohepta[1,2-b]pyridine oral compositions |
| 05/28/2002 | CA2221091C Estrogen agonist/antagonists treatment of atherosclerosis |
| 05/28/2002 | CA2207097C Quinazolinone-containing pharmaceutical compositions and methods for the use thereof |
| 05/28/2002 | CA2203618C New metalloprotease inhibitors, their preparation process and the pharmaceutical compounds that contain them |
| 05/28/2002 | CA2181377C Tetracyclic derivatives, process of preparation and use |
| 05/28/2002 | CA2165433C Novel chemical compounds having pde-iv inhibition activity |
| 05/28/2002 | CA2083274C The pharmacological use of certain cystine derivatives |
| 05/28/2002 | CA2038747C Selective adenosine receptor agents |
| 05/28/2002 | CA1341362C Human manganese superoxide dismutase cdna, its expression in bacteria and method of recovering enzymatically active human manganese superoxide dismutase |
| 05/23/2002 | WO2002040678A1 Small acid-soluble spore protein and uses thereof |
| 05/23/2002 | WO2002040649A1 Slo2 and slo4, novel potassium channel proteins from human brain |
| 05/23/2002 | WO2002040629A2 Promoters exhibiting endothelial cell specificity and methods of using same |
| 05/23/2002 | WO2002040517A2 M. tuberculosis chaperonin 60.1 and uses thereof |
| 05/23/2002 | WO2002040508A2 Lactam dipeptide and its use in inhibiting beta-amyloid peptide release |
| 05/23/2002 | WO2002040505A2 Dibenzoxazepine alpha v integrin receptor antagonist |
| 05/23/2002 | WO2002040488A1 Novel photosensitizers of 9-hydroxypheophorbide-a derivatives used for photocynamic therapy |
| 05/23/2002 | WO2002040487A2 Benzodiazepine derivatives as gaba a receptor modulators |
| 05/23/2002 | WO2002040486A2 METHODS OF TREATING p38 KINASE-ASSOCIATED CONDITIONS AND PYRROLOTRIAZINE COMPOUNDS USEFUL AS KINASE INHIBITORS |
| 05/23/2002 | WO2002040484A2 Novel imidazole derivatives, production method thereof and use thereof |
| 05/23/2002 | WO2002040480A2 Crf receptor antagonists and methods relating thereto |
| 05/23/2002 | WO2002040476A1 Pyridyl-substituted triazoles as tgf inhibitors |